Conjugates of anti-CD24 antibody (G7mAb), nitric oxide (NO), or doxorubicin (DOX) inhibit the growth of hepatocellular carcinoma tumors in mice [82,83]. This evidence concerns the gene CD24 and hepatocellular carcinoma.